Report Detail
Global Ranibizumab Market Growth (Status and Outlook) 2019-2024
- RnM3134500 |
- 18 March, 2019 |
- Global |
- 116 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.
According to this study, over the next five years the Ranibizumab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Ranibizumab business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions.
This study considers the Ranibizumab value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Single-use prefilled syringe
Single-use glass vial
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Genentech
Novartis
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Ranibizumab market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Ranibizumab market by identifying its various subsegments.
Focuses on the key global Ranibizumab players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ranibizumab with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Ranibizumab submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Ranibizumab Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Ranibizumab Market Size 2014-2024
- 2.1.2 Ranibizumab Market Size CAGR by Region
- 2.2 Ranibizumab Segment by Type
- 2.2.1 Single-use prefilled syringe
- 2.2.2 Single-use glass vial
- 2.3 Ranibizumab Market Size by Type
- 2.3.1 Global Ranibizumab Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Ranibizumab Market Size Growth Rate by Type (2014-2019)
- 2.4 Ranibizumab Segment by Application
- 2.4.1 wAMD
- 2.4.2 Diabetic Retinopathy (DR)
- 2.4.3 Diabetic Macular Edema (DME)
- 2.4.4 mCNV
- 2.4.5 RVO
- 2.5 Ranibizumab Market Size by Application
- 2.5.1 Global Ranibizumab Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Ranibizumab Market Size Growth Rate by Application (2014-2019)
3 Global Ranibizumab by Players
- 3.1 Global Ranibizumab Market Size Market Share by Players
- 3.1.1 Global Ranibizumab Market Size by Players (2017-2019)
- 3.1.2 Global Ranibizumab Market Size Market Share by Players (2017-2019)
- 3.2 Global Ranibizumab Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Ranibizumab by Regions
- 4.1 Ranibizumab Market Size by Regions
- 4.2 Americas Ranibizumab Market Size Growth
- 4.3 APAC Ranibizumab Market Size Growth
- 4.4 Europe Ranibizumab Market Size Growth
- 4.5 Middle East & Africa Ranibizumab Market Size Growth
5 Americas
- 5.1 Americas Ranibizumab Market Size by Countries
- 5.2 Americas Ranibizumab Market Size by Type
- 5.3 Americas Ranibizumab Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Ranibizumab Market Size by Countries
- 6.2 APAC Ranibizumab Market Size by Type
- 6.3 APAC Ranibizumab Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Ranibizumab by Countries
- 7.2 Europe Ranibizumab Market Size by Type
- 7.3 Europe Ranibizumab Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Ranibizumab by Countries
- 8.2 Middle East & Africa Ranibizumab Market Size by Type
- 8.3 Middle East & Africa Ranibizumab Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Ranibizumab Market Forecast
- 10.1 Global Ranibizumab Market Size Forecast (2019-2024)
- 10.2 Global Ranibizumab Forecast by Regions
- 10.2.1 Global Ranibizumab Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Ranibizumab Forecast by Type
- 10.8 Global Ranibizumab Forecast by Application
11 Key Players Analysis
- 11.1 Genentech
- 11.1.1 Company Details
- 11.1.2 Ranibizumab Product Offered
- 11.1.3 Genentech Ranibizumab Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Genentech News
- 11.2 Novartis
- 11.2.1 Company Details
- 11.2.2 Ranibizumab Product Offered
- 11.2.3 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Novartis News
...
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Ranibizumab . Industry analysis & Market Report on Ranibizumab is a syndicated market report, published as Global Ranibizumab Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Ranibizumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
